| Literature DB >> 31190292 |
Jiayuan Zhao1, Dongying Jia2, Juan Du3, Yuanlong Chi2, Kai Yao4.
Abstract
Beta-cypermethrin (β-CY) residues are a serious threat to food safety and human health. However, the residues are not efficiently biodegraded because microorganisms preferentially use the nutrients found in food and the environment for growth. In this study, the mechanisms underlying nutrient regulation during co-metabolic degradation of β-CY by Bacillus licheniformis B-1 were investigated. The strain B-1 resting cells and the suspension containing NaN3 showed no significant differences in β-CY degradation. The co-metabolic degradation and strain B-1 growth could be separately inhibited by iodoacetic acid and sodium fluoride. Adenosine monophosphate (AMP), fructose 1-6 bisphosphate (F1-6BP), Mg2+, and Mn2+ could improve the degradation, whereas adenosine triphosphate (ATP), alanine (Ala), phenylalanine (Phe), and phosphoenolpyruvate (PEP) were found to exert the opposite effect, indicating that β-CY degradation was positively associated with pyruvate kinase activity. Furthermore, glycerol, urea, ammonium chloride and peptone improved β-CY degradation in corn flour. The results provided a promising approach for nutrient regulation of pyrethroids biodegradation in food and the environment.Entities:
Keywords: Bacillus licheniformis B-1; Beta-cypermethrin; Biodegradation; Co-metabolism; Substrate regulation
Year: 2019 PMID: 31190292 PMCID: PMC6562013 DOI: 10.1186/s13568-019-0808-3
Source DB: PubMed Journal: AMB Express ISSN: 2191-0855 Impact factor: 3.298
Samples compositions with the different tested compounds
| Sample | MgCl2 (mmol/L) | MnCl2 (mmol/L) | ZnCl2 (mmol/L) | CaCl2 (mmol/L) | ATP (mmol/L) | NADH (mmol/L) | PEP (mmol/L) | AMP (mmol/L) | F1-6BP (mmol/L) | Ala (mmol/L) | Phe (mmol/L) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Control | –a | – | – | – | – | – | – | – | – | – | – |
| 1 | 0.1 | – | – | – | – | – | – | – | – | – | – |
| 2 | 0.5 | – | – | – | – | – | – | – | – | – | – |
| 3 | 1.0 | – | – | – | – | – | – | – | – | – | – |
| 4 | 2.0 | – | – | – | – | – | – | – | – | – | – |
| 5 | – | 0.1 | – | – | – | – | – | – | – | – | – |
| 6 | – | 0.5 | – | – | – | – | – | – | – | – | – |
| 7 | – | 1.0 | – | – | – | – | – | – | – | – | – |
| 8 | – | 2.0 | – | – | – | – | – | – | – | – | – |
| 9 | – | – | 0.1 | – | – | – | – | – | – | – | – |
| 10 | – | – | 0.5 | – | – | – | – | – | – | – | – |
| 11 | – | – | 1.0 | – | – | – | – | – | – | – | – |
| 12 | – | – | 2.0 | – | – | – | – | – | – | – | – |
| 13 | – | – | – | 0.1 | – | – | – | – | – | – | – |
| 14 | – | – | – | 0.5 | – | – | – | – | – | – | – |
| 15 | – | – | – | 1.0 | – | – | – | – | – | – | – |
| 16 | – | – | – | 2.0 | – | – | – | – | – | – | – |
| 17 | – | – | – | – | 5.0 | – | – | – | – | – | – |
| 18 | – | – | – | – | – | 5.0 | – | – | – | – | – |
| 19 | – | – | – | – | – | – | 5.0 | – | – | – | – |
| 20 | – | – | – | – | – | – | 10.0 | – | – | – | – |
| 21 | – | – | – | – | – | – | 15.0 | – | – | – | – |
| 22 | – | – | – | – | – | – | 20.0 | – | – | – | – |
| 23 | – | – | – | – | – | – | – | 5.0 | – | – | – |
| 24 | – | – | – | – | – | – | – | – | 5.0 | – | – |
| 25 | 0.1 | – | – | – | – | – | – | – | 5.0 | – | – |
| 26 | 0.1 | – | – | – | – | – | – | 5.0 | – | – | – |
| 27 | 0.1 | – | – | – | – | – | – | – | – | 5.0 | – |
| 28 | 0.1 | – | – | – | – | – | – | – | – | – | 5.0 |
aNot added
Degradation of β-CY by resting cells and strain B-1 cells in suspension containing NaN3
| Sample | β-CY degradation (%) |
|---|---|
| Strain B-1 suspension | 23.42 ± 0.36a |
| Resting cell | 23.35 ± 0.28a |
| Strain B-1 suspension with NaN3 | 22.55 ± 0.57a |
Data are presented as mean ± standard deviation of three replicates; the standard deviations are within 5% of the mean. Different letters indicate significant differences (p < 0.05)
Fig. 1Effects of glucose metabolism inhibitors on co-metabolic degradation of β-CY by strain B-1. Data are presented as mean ± standard deviation of three replicates; the standard deviations are within 5% of the mean. Different letters indicate significant differences (p < 0.05)
Degradation of β-CY by strain B-1 cells in suspension after the addition of metallic ions
| Metallic ions | Concentrations (mmol/L) | β-CY degradation (%) |
|---|---|---|
| Control | 22.19 ± 0.075a | |
| Mg2+ | 0.1 | 26.14 ± 1.47b |
| 0.5 | 29.51 ± 2.19b | |
| 1.0 | 22.58 ± 1.72a | |
| 2.0 | 21.63 ± 1.42a | |
| Mn2+ | 0.1 | 27.03 ± 0.92b |
| 0.5 | 28.98 ± 2.21b | |
| 1.0 | 25.46 ± 1.43b | |
| 2.0 | 22.59 ± 1.23a | |
| Zn2+ | 0.1 | 22.70 ± 0.23a |
| 0.5 | 22.58 ± 1.41a | |
| 1.0 | 21.09 ± 0.92a | |
| 2.0 | 20.71 ± 2.31a | |
| Ca2+ | 0.1 | 21.92 ± 2.12a |
| 0.5 | 21.79 ± 1.63a | |
| 1.0 | 21.09 ± 1.12a | |
| 2.0 | 20.12 ± 1.53a |
Data are presented as mean ± standard deviation of three replicates; the standard deviations are within 5% of the mean. Different letters indicate significant differences (p < 0.05)
Degradation of β-CY by strain B-1 after the addition of NADH and ATP
| Sample | Concentration (mmol/L) | β-CY degradation (%) |
|---|---|---|
| Control | 23.42 ± 0.36a | |
| Strain B-1 suspension with NADH | 5.0 | 23.35 ± 0.28a |
| Strain B-1 suspension with ATP | 5.0 | 19.85 ± 0.57b |
Data are presented as mean ± standard deviation of three replicates; the standard deviations are within 5% of the mean. Different letters indicate significant differences (p < 0.05)
Degradation of β-CY by strain B-1 after the addition of different concentrations of PEP
| PEP concentrations (mmol/L) | β-CY degradation (%) |
|---|---|
| Control | 22.68 ± 1.28a |
| 5.0 | 22.09 ± 2.12a |
| 10.0 | 17.01 ± 1.06b |
| 15.0 | 14.52 ± 1.24c |
| 20.0 | 12.31 ± 1.10d |
Data are presented as mean ± standard deviation of three replicates; the standard deviations are within 5% of the mean. Different letters indicate significant differences (p < 0.05)
Fig. 2Effects of pyruvate kinase activators on co-metabolic degradation of β-CY by strain B-1. Data are presented as mean ± standard deviation of three replicates; the standard deviations are within 5% of the mean. Different letters indicate significant differences (p < 0.05)
Fig. 3Effect of pyruvate kinase inhibitors on co-metabolic degradation of β-CY by strain B-1. Data are presented as mean ± standard deviation of three replicates; the standard deviations are within 5% of the mean. Different letters indicate significant differences (p < 0.05)
Fig. 4Proposed pathway for nutrient regulation during co-metabolic degradation of β-CY by strain B-1. Co-metabolic degradation of β-CY by strain B-1 was positively associated with the activity of pyruvate kinase, which could be regulated by glucose, glycerol, and nitrogen sources
Fig. 5Effects of the addition of carbon (a) and nitrogen sources (b) on co-metabolic degradation of β-CY in corn flour by strain B-1. Data are presented as mean ± standard deviation of three replicates; the standard deviations are within 5% of the mean. Different letters indicate significant differences (p < 0.05)